Regeneron Pharmaceuticals Inc. buy kyron7htx
Start price
04.12.18
/
50%
€351.26
Target price
07.05.19
€451.00
Performance (%)
-15.70%
End price
07.05.19
€296.10
Summary
This prediction ended on 07.05.19 with a price of €296.10. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -15.70%. kyron7htx has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 4.014% | 4.014% | 46.781% | -3.625% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by kyron7htx for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Ein
Aufwärtstrend ist zu sehen.
(Vom Mitglied beendet)